Answers are grounded in this paper and cite their sources.
There is virtual unanimity that the optimal treatment for most patients with end-stage renal disease is renal transplantation. However, unlike the case for liver, heart, and lung transplantation, for which no long-term successful alternative is available, dialysis is also an option in patients with end-stage renal disease, prolonging survival. The benefits of renal transplantation have usually been described in terms of a better quality of life1 and reduced medical expenses2 rather than the prolongation of life. In this issue of the Journal, 27 years after the establishment of federal funding for the treatment of end-stage renal disease and with the . . .
No takes yet. Share an insight, caveat, or question.
Lawrence G. Hunsicker (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: